Outcomes After Conservative Treatment of Advanced-Stage Serous Borderline Tumors of the Ovary

Ann Oncol. 2010 Jan 1;21(1):55-60, C Uzan, A Kane, A Rey, S Gouy, P Duvillard, P Morice

TAKE-HOME MESSAGE

Abstract

SUMMARY

OncologySTAT Editorial Team

The main purpose of conservative treatment for young patients with low-malignant-potential ovarian tumors (LMPOT) is to preserve fertility. Yet few studies of conservative treatment for advanced-stage LMPOT include fertility outcomes, and the safety of conservative treatment in these patients is still open to debate. In the current study, Uzan et al report recurrence rates, survival rates, and fertility outcomes on the largest series of patients treated conservatively for advanced-stage (stage II...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

About Our Journal Scans

View a list of journals that the OncologySTAT editorial team scans every week in order to bring you the most practice-relevant original research and review articles.

Sign up for our newsletters

Too busy to follow cancer's top stories? Sign-up for 1 or more of our free newsletters -- delivered weekly to your inbox.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration